Durata Therapeutics, Inc.
DelistedCIK 1544116fmd_0HZMJ0MBW6Q4VDA4Y3WQ45MEG6Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2014, 16 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 |
|---|---|---|---|---|
| Net interest income | (0) | (0) | (0) | – |
| Research and development | 5 | 30 | 52 | 37 |
| Operating income | 14 | (36) | (63) | (57) |
| Income before taxes | 14 | (36) | (63) | (61) |
| Income tax expense | 3 | (3) | 0 | 1 |
| Net income from continuing operations | 11 | (33) | (63) | (62) |
| Net income | (11) | (33) | (63) | (62) |
| Net income to common shareholders | (11) | (33) | (63) | – |